سعر سيفزيم 2 جم فيال 2024

Cefzim 2 gm vial: Ceftazidime (Pharco B).

• Parenteral third-generation cephalosporin with antipseudomonal activity for susceptible infections including lower respiratory tract, skin/skin structure, urinary tract, bacterial septicemia, bone and joint, gynecologic, intra-abdominal, and CNS infections as labeled (US ceftazidime injectable labeling).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Local reactions, gastrointestinal symptoms, hypersensitivity, and hematologic/hepatic lab changes reported; see full US label for frequencies.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated in patients with known allergy to the cephalosporin group of antibiotics (US Ceftazidime injectable labeling).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Serious hypersensitivity reactions possible; Clostridioides difficile–associated diarrhea reported with nearly all antibacterials; monitor and manage per label (US injectable cephalosporin labeling).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Animal studies without clear teratogenicity at multiples of human dose; limited adequate controlled human data — use only if clearly needed (US labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Low concentrations excreted in human milk; caution in nursing women (US labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Ceftazidime: Parenteral third-generation cephalosporin inhibiting cell-wall synthesis; notable activity against Pseudomonas aeruginosa.